Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2009 3
2010 3
2011 3
2012 4
2013 7
2014 9
2015 7
2016 2
2017 3
2018 6
2019 5
2020 1
2021 5
2022 3
2023 5
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence of Hepatitis B Virus Infection in Isfahan Province.
Nokhodian Z, Adibi P, Ataei B. Nokhodian Z, et al. Int J Prev Med. 2014 Dec;5(Suppl 3):S193-9. Int J Prev Med. 2014. PMID: 26622989 Free PMC article. Review.
Hepatitis B virus (HBV) is a serious global health problem. It is estimated that 1.5-2.5 million people are suffering from this infection in Iran. ...
Hepatitis B virus (HBV) is a serious global health problem. It is estimated that 1.5-2.5 million people are suffering from this infec …
Homocysteine-Lowering Interventions in Chronic Kidney Disease.
Badri S, Vahdat S, Seirafian S, Pourfarzam M, Gholipur-Shahraki T, Ataei S. Badri S, et al. J Res Pharm Pract. 2021 Dec 25;10(3):114-124. doi: 10.4103/jrpp.jrpp_75_21. eCollection 2021 Jul-Sep. J Res Pharm Pract. 2021. PMID: 35198504 Free PMC article. Review.
Most treatments, which lower Hcy levels and have been considered in previous studies, include folic acid, B vitamins, omega-3 fatty acids, and N-acetylcysteine. However, the effect of therapies that can decrease Hcy levels and thus cardiovascular events in these patients i …
Most treatments, which lower Hcy levels and have been considered in previous studies, include folic acid, B vitamins, omega-3 fatty a …
Synergistic HNO3-H2SO4-NH3 upper tropospheric particle formation.
Wang M, Xiao M, Bertozzi B, Marie G, Rörup B, Schulze B, Bardakov R, He XC, Shen J, Scholz W, Marten R, Dada L, Baalbaki R, Lopez B, Lamkaddam H, Manninen HE, Amorim A, Ataei F, Bogert P, Brasseur Z, Caudillo L, De Menezes LP, Duplissy J, Ekman AML, Finkenzeller H, Carracedo LG, Granzin M, Guida R, Heinritzi M, Hofbauer V, Höhler K, Korhonen K, Krechmer JE, Kürten A, Lehtipalo K, Mahfouz NGA, Makhmutov V, Massabò D, Mathot S, Mauldin RL, Mentler B, Müller T, Onnela A, Petäjä T, Philippov M, Piedehierro AA, Pozzer A, Ranjithkumar A, Schervish M, Schobesberger S, Simon M, Stozhkov Y, Tomé A, Umo NS, Vogel F, Wagner R, Wang DS, Weber SK, Welti A, Wu Y, Zauner-Wieczorek M, Sipilä M, Winkler PM, Hansel A, Baltensperger U, Kulmala M, Flagan RC, Curtius J, Riipinen I, Gordon H, Lelieveld J, El-Haddad I, Volkamer R, Worsnop DR, Christoudias T, Kirkby J, Möhler O, Donahue NM. Wang M, et al. Nature. 2022 May;605(7910):483-489. doi: 10.1038/s41586-022-04605-4. Epub 2022 May 18. Nature. 2022. PMID: 35585346 Free PMC article.
Seroprevalence of hepatitis B markers among incarcerated intravenous drug users.
Nokhodian Z, Yaran M, Adibi P, Kassaian N, Meshkati M, Ataei B. Nokhodian Z, et al. J Res Med Sci. 2014 Mar;19(Suppl 1):S13-6. J Res Med Sci. 2014. PMID: 25002887 Free PMC article.
BACKGROUND: Drug injection is one of the most prominent risk factors for transmission of viral hepatitis. Prevalence of hepatitis B virus (HBV) is generally higher in prisoners compared with the general population. ...Sera were analyzed for markers of the hepatitis B …
BACKGROUND: Drug injection is one of the most prominent risk factors for transmission of viral hepatitis. Prevalence of hepatitis B v …
Clinical and radiologic manifestation B-cell mediated autoimmune diseases of central nervous system.
Afzali M, Etemadifar M, Ataei A, Tavakoli H, Shafieyoun A. Afzali M, et al. Am J Clin Exp Immunol. 2020 Jun 15;9(3):28-40. eCollection 2020. Am J Clin Exp Immunol. 2020. PMID: 32704432 Free PMC article.
B-cell mediated autoimmune diseases of central nervous system (CNS) put a heavy burden on different aspects of society and economy. ...The aim of this study is to distinguish B-cell mediated autoimmune diseases of CNS from other non-B-cell diseases in order t …
B-cell mediated autoimmune diseases of central nervous system (CNS) put a heavy burden on different aspects of society and economy. . …
Disease Waves of SARS-CoV-2 in Iran Closely Mirror Global Pandemic Trends.
Fattahi Z, Mohseni M, Beheshtian M, Jafarpour A, Jalalvand K, Keshavarzi F, Behravan H, Ghodratpour F, Zare Ashrafi F, Kalhor M, Azad M, Koshki M, Ghaziasadi A, Soveyzi M, Abdollahi A, Kiani SJ, Ataei-Pirkooh A, Rezaeiazhar I, Bokharaei-Salim F, Haghshenas MR, Babamahmoodi F, Mokhames Z, Soleimani A, Elahi Z, Ziaee M, Javanmard D, Ghafari S, Ezani A, Ansari Moghaddam A, Shahraki-Sanavi F, Hashemi Shahri SM, Azaran A, Yousefi F, Moattari A, Moghadami M, Fakhim H, Ataei B, Nasri E, Poortahmasebi V, Varshochi M, Mojtahedi A, Jalilian F, Khazeni M, Moradi A, Tabarraei A, Piroozmand A, Yahyapour Y, Bayani M, Tavangar F, Yaghoubi M, Keramat F, Tavakoli M, Jalali T, Pouriayevali MH, Salehi-Vaziri M, Khorram Khorshid HR, Najafipour R, Malekzadeh R, Kahrizi K, Jazayeri SM, Najmabadi H. Fattahi Z, et al. Arch Iran Med. 2022 Aug 1;25(8):508-522. doi: 10.34172/aim.2022.83. Arch Iran Med. 2022. PMID: 37543873 Free article.
RESULTS: The temporal dynamics of major SARS-CoV-2 clades/lineages circulating in Iran is comparable to the global perspective and represent the 19A clade (B.4) dominating the first disease wave, followed by 20A (B.1.36), 20B (B.1.1.413), 20I (B.1.1.7) …
RESULTS: The temporal dynamics of major SARS-CoV-2 clades/lineages circulating in Iran is comparable to the global perspective and represent …
The role of melatonin on radiation-induced pneumonitis and lung fibrosis: A systematic review.
Sheikholeslami S, Aryafar T, Abedi-Firouzjah R, Banaei A, Dorri-Giv M, Zamani H, Ataei G, Majdaeen M, Farhood B. Sheikholeslami S, et al. Life Sci. 2021 Sep 15;281:119721. doi: 10.1016/j.lfs.2021.119721. Epub 2021 Jun 16. Life Sci. 2021. PMID: 34146555
Moreover, melatonin through its anti-inflammatory effects, can attenuate the increased levels of nuclear factor kappa B, tumor necrosis factor alpha, transforming growth factor beta 1, SMAD2, interleukin (IL)-4, IL-4 receptor-a1 (IL4ra1), and IL-1 beta following lung radia …
Moreover, melatonin through its anti-inflammatory effects, can attenuate the increased levels of nuclear factor kappa B, tumor necros …
Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran.
Mozhgani SH, Malekpour SA, Norouzi M, Ramezani F, Rezaee SA, Poortahmasebi V, Sadeghi M, Alavian SM, Zarei-Ghobadi M, Ghaziasadi A, Karimzadeh H, Malekzadeh R, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Jahantigh HR, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Keyvani H, Kalantari E, Fakhari Z, Geravand B, Jazayeri SM. Mozhgani SH, et al. Arch Virol. 2018 Jun;163(6):1479-1488. doi: 10.1007/s00705-018-3764-3. Epub 2018 Feb 13. Arch Virol. 2018. PMID: 29442226
Previous local and national Iranian publications indicate that all Iranian hepatitis B virus (HBV) strains belong to HBV genotype D. The aim of this study was to analyze the evolutionary history of HBV infection in Iran for the first time, based on an intensive phylodynami …
Previous local and national Iranian publications indicate that all Iranian hepatitis B virus (HBV) strains belong to HBV genotype D. …
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Disease and Injury and Risk Factor Collaborators. GBD 2023 Disease and Injury and Risk Factor Collaborators. Lancet. 2025 Oct 18;406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092926 Free PMC article.
71 results